ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 793

Mesenchymal Stem Cells Promote the Generation of CD206+ Macrophage and Increase Its Phagocytic Activity in Systemic Lupus Erythematosus

Wei Deng, Weiwei Chen, Zhuoya Zhang, Saisai Huang, Wei Kong, Yue Sun, Xuebing Feng, Xiaojun Tang, Genhong Yao and Lingyun Sun, Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: macrophages, Mesenchymal stem cells, phagocytosis, phenotypes and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Umbilical cord (UC)-derived mesenchymal stem cells (MSCs) have been confirmed to exert therapeutic effects on systemic lupus erythematosus (SLE). Deficiency in SLE macrophages exhibits excessive activation and inefficient clearance of self nuclear antigens. However, whether the benefit effect of UCMSCs on SLE was mediated by regulatory effects on macrophages remains to be elucidated. We aim to explore whether UCMSCs could educate SLE macrophage to become a kind of alternatively activated macrophage and increase its phagocytic activity.

Methods:  UCMSCs were injected into B6.MRL-Faslpr mice. The therapeutic effects of MSCs transplantation were evaluated by the renal pathology, proteinuria, spleen index, T lymphocyte subpopulation and plasma cells. Murine peritoneal/renal macrophages were isolated to detect the proportion of alternatively activated macrophage (F4/80+CD206+). To determine the phagocytic activity of murine peritoneal/renal macrophages, FITC-labeled flurospheres were added into the cultures. The uptake of FITC-labeled flurospheres was determined by flow cytometry. CD14+ monocytes were isolated from peripheral blood of healthy donors (HC) and SLE patients. We cultured human monocytes for 7 days with macrophage colony-stimulating factor (M-CSF) to generate macrophages, and then cocultured them for 2 more days with UCMSCs in a transwell culture system. The levels of CD206 and phagocytic activity of macrophages were detected by flow cytometry.

Results:  Compared with C57BL/6 mice, B6.MRL-Faslpr mice macrophages exhibited lower level of CD206, the marker of alternatively activated macrophages. In addition, the phagocytic activity of B6.MRL-Faslpr mice macrophages was also decreased. UCMSCs transplantation could rescue both the proportion of CD206+ macrophages and the phagocytic activity. Interestingly, the proportion of CD206+ macrophages was positively correlated with the phagocytic activity. Similar to the lupus mice, macrophages from SLE patients showed lower expression of CD206 and phagocytic activity. SLE macrophages cocultured with UCMSCs consistently increased the expression of CD206 and phagocytic activity. In addition, the up-regulation of phagocytic activity by UCMSCs was only appeared in CD206+ macrophages. This phenomenon was also observed in UCMSCs transplanted SLE patients. Furthermore, the addition of specific neutralizing antibodies/inhibitor/siRNA of HGF, TGFβ1, PGE2 and HO-1 could not reverse the effects of UCMSCs on SLE macrophages.

Conclusion:  UCMSCs could alleviate SLE through promoting the generation of CD206+ macrophage and increasing its phagocytic activity, and these effects was independent of HGF, TGFβ1, PGE2 and HO-1.


Disclosure: W. Deng, None; W. Chen, None; Z. Zhang, None; S. Huang, None; W. Kong, None; Y. Sun, None; X. Feng, None; X. Tang, None; G. Yao, None; L. Sun, None.

To cite this abstract in AMA style:

Deng W, Chen W, Zhang Z, Huang S, Kong W, Sun Y, Feng X, Tang X, Yao G, Sun L. Mesenchymal Stem Cells Promote the Generation of CD206+ Macrophage and Increase Its Phagocytic Activity in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/mesenchymal-stem-cells-promote-the-generation-of-cd206-macrophage-and-increase-its-phagocytic-activity-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mesenchymal-stem-cells-promote-the-generation-of-cd206-macrophage-and-increase-its-phagocytic-activity-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology